CORCEPT THERAPEUTICS INC - 10-Q Filing
Corcept Therapeutics reported Q2 revenue of $256.1M, up from $194.4M in the same period last year.
Tickers: $CORT
More Regulatory news
- Ideal Power Inc. - 8-K Filing
- DIGI INTERNATIONAL INC - 8-K Filing
- ZeroStack Corp. - 8-K Filing
- Sound Point Meridian Capital, Inc. - 8-K Filing
- Boost Run Inc. - 8-K Filing
- INTERFACE INC - 8-K Filing
- Neonode Inc. - 10-Q Filing
- Virtuix Holdings Inc. - 8-K Filing
- Neonode Inc. - 8-K Filing
- Beyond Air, Inc. - 10-Q Filing